OLIVIA MOTSIS: Open Payments
NPI 1306419460 · NEWBURYPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 41 payments from 11 companies in 2025. Trend: 2023 $840 · 2024 $582 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $255 |
| E.R. Squibb & Sons, L.L.C. | 15 | $245 |
| Edwards Lifesciences Corporation | 1 | $124 |
| PFIZER INC. | 4 | $107 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| Philips North America LLC | 1 | $41 |
| Amgen Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
Products named: CAMZYOS, FARXIGA, SAPIEN 3 Ultra RESILIA, ELIQUIS, WAINUA, LEQVIO, NEXLETOL, Extended Holter.
Industry payments across MA — which companies pay providers there.
